Related Experiment Video

Updated: Aug 6, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

[Pathogenesis of disturbances of the hemostatic system in neonates]

O I Zhdanovych

    Likars'Ka Sprava
    |August 25, 2001
    PubMed

    Insights

    Neonatal hemostasis and erythron system disturbances are linked to maternal extragenital pathologies. Specific interventions are developed for infants with diabetic fetopathy or born to mothers with neurocirculatory asthenia.

    Area of Science:

    • Neonatal physiology
    • Hematology
    • Pathophysiology

    Context:

    • Maternal extragenital pathologies significantly impact neonatal health.
    • Understanding neonatal hemostasis and erythron system is crucial.

    Purpose:

    • To elucidate the pathogenetic mechanisms of hemostasis and erythron system disturbances in neonates born to mothers with extragenital pathologies.
    • To identify specific risk factors and clinical presentations associated with these disturbances.

    Summary:

    • Neonates born to mothers with extragenital pathologies exhibit significant clotting and erythron system changes.
    • Vascular permeability disorders and metabolic abnormalities are also observed, particularly in infants with diabetic fetopathy or born to mothers with neurocirculatory asthenia.
    • These findings highlight complex interconnections between maternal health and neonatal development.

    Impact:

    • The study results facilitated the development of targeted curative and prophylactic measures for affected neonates.
    • This research contributes to improved neonatal care strategies for high-risk pregnancies.
    • Enhanced understanding of neonatal pathophysiology can lead to better clinical outcomes.

    More Related Videos

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin07:57

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

    Published on: August 25, 2022

    Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock09:09

    Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

    Published on: November 3, 2023

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Extrinsic and Intrinsic Pathways of Hemostasis01:20

    Extrinsic and Intrinsic Pathways of Hemostasis

    Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
    The Extrinsic Pathway
    The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
    Disorders of Hemostasis01:24

    Disorders of Hemostasis

    Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
    Thromboembolic Disorders
    Two factors primarily cause thromboembolic conditions.
    Hemorrhagic Stroke ll: Pathophysiology01:29

    Hemorrhagic Stroke ll: Pathophysiology

    A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...